Pluristem Therapeutics (PSTI) Short Interest Ratio & Short Volume → Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad) Free PSTI Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Pluristem Therapeutics Short Interest DataCurrent Short Volume391,400 sharesPrevious Short Volume349,000 sharesChange Vs. Previous Month+12.15%Dollar Volume Sold Short$481,422.00Short Interest Ratio / Days to Cover3.8Last Record DateJune 30, 2022Outstanding Shares32,348,000 sharesPercentage of Shares Shorted1.21%Today's Trading Volume2,128 sharesAverage Trading Volume715,259 sharesToday's Volume Vs. Average0% Short Selling Pluristem Therapeutics ? Sign up to receive the latest short interest report for Pluristem Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPSTI Short Interest Over TimePSTI Days to Cover Over TimePSTI Percentage of Float Shorted Over Time Ad AltimetrySecret Bull Market Starts in This Unusual Sector"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch. Click for my No. 1 investment, all free of charge, click here. Pluristem Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/2022391,400 shares $481,422.00 +12.2%N/A3.8 $1.23 6/15/2022349,000 shares $425,780.00 -28.4%N/A2.7 $1.22 5/31/2022487,300 shares $643,236.00 -17.0%1.9%3.2 $1.32 5/15/2022587,000 shares $857,020.00 -1.0%2.3%3.4 $1.46 4/30/2022592,800 shares $901,056.00 -3.8%2.3%3.1 $1.52 4/15/2022616,100 shares $1.14 million +5.4%2.4%2.6 $1.85 Get the Latest News and Ratings for PSTI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pluristem Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 3/31/2022584,400 shares $1.21 million -23.7%2.3%0.4 $2.07 3/15/2022765,900 shares $1.46 million -6.7%3.0%0.5 $1.91 2/28/2022821,100 shares $1.48 million -6.9%3.2%0.6 $1.80 2/15/2022881,900 shares $1.58 million +9.0%3.4%0.6 $1.79 1/31/2022808,800 shares $1.39 million -9.6%3.1%0.6 $1.72 1/15/2022894,800 shares $1.73 million +148.5%3.2%0.6 $1.93 12/31/2021360,100 shares $525,746.00 +6.3%N/A0 $1.46 12/15/2021338,800 shares $725,032.00 -14.9%1.2%1.6 $2.14 11/30/2021397,900 shares $1.08 million +12.4%1.4%2.2 $2.71 11/15/2021354,000 shares $1.04 million -17.0%1.3%2 $2.93 10/29/2021426,300 shares $1.13 million +31.9%1.5%2.3 $2.65 10/15/2021323,100 shares $846,522.00 -5.5%1.2%1.6 $2.62 9/30/2021341,900 shares $906,035.00 -1.3%1.2%1.6 $2.65 9/15/2021346,400 shares $1.03 million -3.4%1.2%1.5 $2.96 8/31/2021358,400 shares $1.08 million -31.2%1.3%1.5 $3.02 8/13/2021520,600 shares $1.64 million -8.4%1.9%1.5 $3.15 7/30/2021568,100 shares $1.86 million -5.1%2.1%1.6 $3.28 7/15/2021598,600 shares $2.27 million -14.1%2.2%1.5 $3.79 6/30/2021697,000 shares $2.76 million +127.7%2.6%1.7 $3.96 6/15/2021306,100 shares $1.27 million +42.1%1.1%0.7 $4.16 5/28/2021215,400 shares $792,672.00 +4.1%0.8%0.5 $3.68 5/14/2021207,000 shares $732,780.00 +10.1%N/A0.5 $3.54 4/30/2021188,000 shares $812,160.00 -6.6%N/A0.4 $4.32 4/15/2021201,200 shares $883,268.00 -21.7%N/A0.4 $4.39 3/31/2021257,000 shares $1.15 million -26.5%N/A0.3 $4.49 3/15/2021349,600 shares $1.90 million -28.6%N/A0.4 $5.43 2/26/2021489,800 shares $3.09 million -12.4%N/A0.6 $6.31 2/12/2021558,900 shares $4.45 million -43.4%N/A0.7 $7.97 1/29/2021987,000 shares $7.02 million -14.9%N/A1.3 $7.11 1/15/20211,160,000 shares $9.44 million +39.5%N/A1.9 $8.14 12/31/2020831,600 shares $6.14 million -22.3%N/A1.5 $7.38 12/15/20201,070,000 shares $6.56 million -13.7%N/A2.7 $6.13 11/30/20201,240,000 shares $11.88 million +2.5%N/A3.9 $9.58 11/15/20201,210,000 shares $11.10 million -1.6%N/A4.7 $9.17Did You Get Your Free Bitcoin Yet? (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here PSTI Short Interest - Frequently Asked Questions What is Pluristem Therapeutics' current short interest? Short interest is the volume of Pluristem Therapeutics shares that have been sold short but have not yet been covered or closed out. As of June 30th, traders have sold 391,400 shares of PSTI short. Learn More on Pluristem Therapeutics' current short interest. What is a good short interest ratio for Pluristem Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PSTI shares currently have a short interest ratio of 4.0. Learn More on Pluristem Therapeutics's short interest ratio. Is Pluristem Therapeutics' short interest increasing or decreasing? Pluristem Therapeutics saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 391,400 shares, an increase of 12.1% from the previous total of 349,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Pluristem Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Pluristem Therapeutics: Protara Therapeutics, Inc. (0.71%), Achilles Therapeutics plc (0.19%), MiNK Therapeutics, Inc. (0.42%), IN8bio, Inc. (0.18%), CASI Pharmaceuticals, Inc. (1.31%), Pluri Inc. (0.33%), Cyclo Therapeutics, Inc. (0.36%), Estrella Immunopharma, Inc. (0.08%), OKYO Pharma Limited (0.99%), Quince Therapeutics, Inc. (6.21%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.48 billion), Occidental Petroleum Co. ($3.23 billion), TC Energy Co. ($2.86 billion), Lucid Group, Inc. ($2.34 billion), T. Rowe Price Group, Inc. ($1.87 billion), HP Inc. ($1.83 billion), GameStop Corp. ($1.63 billion), Coinbase Global, Inc. ($1.53 billion), Rivian Automotive, Inc. ($1.45 billion), and Lumen Technologies, Inc. ($1.42 billion). View all of the most shorted stocks. What does it mean to sell short Pluristem Therapeutics stock? Short selling PSTI is an investing strategy that aims to generate trading profit from Pluristem Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Pluristem Therapeutics? A short squeeze for Pluristem Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PSTI, which in turn drives the price of the stock up even further. How often is Pluristem Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PSTI, twice per month. The most recent reporting period available is June, 30 2022. More Short Interest Resources from MarketBeat Related Companies: TARA Short Squeeze ACHL Short Squeeze INKT Short Squeeze INAB Short Squeeze CASI Short Squeeze PLUR Short Squeeze CYTH Short Squeeze ESLA Short Squeeze OKYO Short Squeeze QNCX Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PSTI) was last updated on 4/20/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTISHOCKING Crypto Leak…Crypto 101 MediaYour Money is Not SafeAmerican AlternativeThe #1 Crypto for 2024InvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent alert: open this for a huge profit potentialTimothy SykesTiny Biotech Stock Wins $75 Billion PatentBehind the Markets